Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06028776
Other study ID # MS_Ballroom_Fit
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2023
Est. completion date December 22, 2023

Study information

Verified date August 2023
Source University of Aarhus
Contact Lars Hvid
Phone 93508717
Email lhvid@ph.au.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of the present study is to evaluate the effects of a dance-based concept entitled MS Ballroom Fitness (developed in Denmark by PT Elisabeth Dalsgaard) in persons with multiple sclerosis (pwMS). A total of 66 pwMS will be enrolled and equally randomized into an intervention group or a control-waitlist group. Those in the intervention group will undertake 7 weeks of MS Ballroom Fitness, with 2 sessions per week. The investigators assume that balance, walking capacity as well as well-being will be improved.


Description:

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system (CNS) causing demyelination of axons within the CNS as well as loss of axons and neurons. While a wide range of symptoms potentially develops due to the pathology of MS, lower extremity motor function appears preferentially affected. It is therefore not surprising that substantial impairments in balance and walking capacity have been reported in pwMS, based on both subjective (patient perspectives) and objective assessments. This is problematic as balance and walking capacity are rated among the most important bodily functions, and furthermore associated with mental well-being and quality of life. In pwMS, balance can be comprehensively assessed by the mini balance evaluation systems test (miniBEST), specifically evaluating dynamic balance, functional mobility, and gait. As for walking capacity, this can be comprehensively assessed by using a 'simple' short distance walk test (e.g., the timed 25 foot maximal walk test (T25FWT)), a 'complex' short distance walk test (e.g., the six spot step test (SSST)) that involves challenging components of coordination and dynamic balance, alongside a long distance 'endurance' walk test (e.g., the 6-minute maximal walk test (6MWT)) that can also help capture motor fatigability. In addition to these, the 12-item MS Walking Scale (MSWS-12) are commonly used to assess the patient-reported impact of MS on different aspects of walking ability. Different modalities of exercise therapy have been shown effective in counteracting the deterioration of balance and walking capacity observed in pwMS, with improvements reported across all the tests outlined above. Interestingly, dance (including mixed modalities with a predominant dance-based content) appear particularly potent in terms of targeting impairments in balance AND walking capacity. Whilst some pilot/exploratory studies involving pwMS exist, the summarized evidence appear sparse and contain three major limitations. First, the majority of pwMS studies are small exploratory non-controlled studies lacking sample size calculations. Second, none of the identified dance studies provide a personalized approach, i.e., by designing interventions that embrace the needs and physical functional level of each participant. Third, none of the identified dance studies have assessed whether dance-induced adaptations in balance and walking capacity are accompanied by - or even translates into - improvements in mental well-being and quality of life. Physiotherapist Elisabeth Dalsgaard has developed a dance-based concept entitled MS Ballroom FitnessTM (abbreviated MSB-Fit) with a specific focus on joy of life and inclusion. It is specifically adapted to pwMS, having three difficulty levels that correspond to three overall disability categories (sitting, standing, and walking pwMS).


Recruitment information / eligibility

Status Recruiting
Enrollment 66
Est. completion date December 22, 2023
Est. primary completion date December 22, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - self-reported MS diagnosis - patient-determined disease steps (PDDS) = 7 (7 correspond to use a wheelchair for most daily activities) - able to independently attend the testing Exclusion Criteria: - self-reported comorbidities excluding participation in the intervention - substantial cognitive impairments hindering participation - recent fractures (6 months) - critical physical impairments hindering participation in the described training study - participation in structured exercise therapy (including dancing) for the past 3 months (= 2 session per week of moderate-to-high intensity)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
MS Ballroom Fitness
A personalized dance-based concept focusing on balance, walking capacity, and well-being.

Locations

Country Name City State
Denmark Aarhus University, Exercise Biology Aarhus C Jutland

Sponsors (2)

Lead Sponsor Collaborator
University of Aarhus The Danish MS Society

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Six spot step test (SSST) Objective test that measures walking coordination and balance. Unit: seconds. Change from Baseline to 7 weeks
Primary WHO5 wellbeing Questionnaire that measures current mental well-being. Unit: score (0-100; 100 is better). Change from Baseline to 7 weeks
Secondary Static balance Objective test that measures static balance (total score based on 5 different tests; 10s parallel foot stand, 10s semi-parallel foot stand, 10s tandem foot stand, 20s right leg foot stand, 20s left leg foot stand). Unit: seconds (0-70s; 70s is better) Change from Baseline to 7 weeks
Secondary Functional reach test Objective test that measures how far a person can reach with one arm in standing position. Unit: cm. Change from Baseline to 7 weeks
Secondary Modified functional reach test Objective test that measures how far a person can reach (forward, left, right) with one arm in sitting position. Unit: cm.
NB: This test is used for wheel-chair users only.
Change from Baseline to 7 weeks
Secondary Four square step test Objective test that measures dynamic stability and co-ordination. Unit: s. Change from Baseline to 7 weeks
Secondary 6-minute walk test Objective test that measures walking endurance. Unit: meters. Change from Baseline to 7 weeks
Secondary Ottawa sitting scale Rater-evaluated test that measures the level of trunk impairments and sitting balance. Unit: score (0-24; 24 is better).
NB: This test is used for wheel-chair users only.
Change from Baseline to 7 weeks
Secondary Patient determined disease steps Questionnaire that measures level of disability in multiple sclerosis. Unit: score (0-8; 0 is better). Change from Baseline to 7 weeks
Secondary Multiple Sclerosis Walking Scale Questionnaire that measures walking limitations in multiple sclerosis. Unit: score (0-100; 0 is better). Change from Baseline to 7 weeks
Secondary European Quality of life - 5 Dimensions (EuroQOL5D) Questionnaire that measures quality of life. Unit: score (0-100; 0 is better). Change from Baseline to 7 weeks
Secondary Modified fatigue impact scale Questionnaire that measures the impact fatigue has on daily life. Unit: score (0-84; 0 is better) Change from Baseline to 7 weeks
Secondary Falls-efficacy scale - international Questionnaire that measures concerns about falling. Unit: score (16-64; 16 is better) Change from Baseline to 7 weeks
Secondary Falls Number of falls in the past year Change from Baseline to 7 weeks
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4